Orrick logo
  1. Home
  2. People
  3. Hacohen, Tal

Tal Hacohen

Partner

New York

Tal Hacohen is a partner in the Corporate Group of Orrick’s New York office and is a member of the Global Mergers & Acquisitions and Private Equity Group.

Tal represents U.S. and multinational public and private company clients in a variety of transactions and across industries, including domestic and cross-border mergers, acquisitions, dispositions, private placements and restructurings.  Tal also advises boards of directors and shareholders in all aspects of New York and Delaware corporate, partnership and limited liability company law, including corporate governance and fiduciary duty matters.

In addition, Tal represents numerous early- and growth-stage technology companies (with a particular focus on Israeli-related companies) in equity and debt financing rounds and general corporate matters.

Tal was recently recognized as a "40 under 40 Emerging Leader" by The M&A Advisor, an "Acritas Star" by Acritas and a “Rising Star” by IFLR for his work in the area of Mergers & Acquisitions.

  • Tal's recent engagements include:

    • Vitech Systems Group, Inc. in its sale of a majority interest to affiliates of CVC Capital Partners
    • Affiliates of Prominent Private Equity Sponsors in the acquisition of a majority interest in a life settlements portfolio SPV
    • Velocity Pharmaceutical Development, Inc. in the sale of a portfolio company
    • Henkel AG & Co. in its acquisition of a majority interest in eSalon
    • Superior Plus Corp. and its affiliates in several transactions, including the $900 million acquisition of the retail propane business of NGL Energy Partners and the $325 million divestiture of its construction products distribution business
    • Compass Real Estate in several acquisitions of real estate brokerages and development companies
    • Code Tech Corp. in its sale to Pro Mach, an affiliate of Leonard Green & Partners
    • Sailthru, Inc., in its sale to Campaign Monitor, a portfolio company of Insight Venture Partners
    • Stitch, Inc. in its sale to Talend, Inc.
    • Insomnia Cookies, in its sale to Krispy Kreme Doughnuts
    • RAG-Stiftung Investment Company in several transactions, including its acquisitions of Alfa Tech Consulting Enterprises, SecurView, Inc. and Invotech Engineering
    • Vettery, Inc. in its sale to Adecco Group
    • Parmalat S.p.A. in its acquisition of Karoun Dairies and Central Valley
    • CoorsTek, Inc. in several acquisitions, including its acquisition of the global Advanced Ceramics division of Saint-Gobain.
    • Naturex SA and its worldwide affiliates in several transactions, including the acquisition of assets from Haliburton Foods, the acquisition of Decas Botanical Synergies and the joint venture with Aker BioMarine
    • DRT, in its $150 million acquisition of Pinova, Inc.
    • LINTEC Corporation, in its $375 million acquisition of MACtac Americas
    • Veolia Environnement S.A., in its $325 million acquisition of the Sulfur Products division of The Chemours Company
    • Canal+ Groupe/Thema, in its acquisition of Alterna'TV
    • Flamel Technologies (NASDAQ: FLML), in its acquisition and subsequent disposition of FSC Holdings
    • Pactera Technology International, Ltd., in its acquisition of Blue Fountain Media
    • XO Group Inc. (NYSE: XOXO), in its acquisition of GigMasters.com
    • 9th Street Capital, in its acquisition of Liberty Woods International
    • IFM Investors Pty. Ltd., in its $5.72 billion acquisition of ITR Concession Company, LLC
    • TouchTunes Interactive Networks, Inc., in its sale to Searchlight Capital
    • LivePerson, Inc. (NASDAQ: LPSN), in several acquisitions, including its $65 million acquisition of Contact At Once!, LLC
    • ZipRealty, Inc. (NASDAQ: ZIPR), in its $166 million merger with Realogy Group, LLC
    • Bureau Veritas, in several strategic acquisitions of inspection services companies
    • Golden Equity Investments, in its acquisitions of several portfolio companies, including Mad Greens LLC and iMDS Corp.      
    • Par Pharmaceutical Companies, Inc. (NYSE: PRX), in its $1.9 billion all cash acquisition by TPG Capital.
    • Par Pharmaceutical, Inc., in its $410 million acquisition of Anchen Pharmaceuticals and in several product acquisitions and licensing arrangements.
    • Paddock Laboratories, Inc., in its $540 million sale to Perrigo Company.
    • Sigma-Tau Pharmaceuticals, Inc., in its $327 million acquisition of the specialty products division of Enzon Pharmaceuticals, Inc.
      •        

    In addition, for the last several years Tal has worked extensively with Mercy Corps International in various strategic investments in social impact organizations and the Explore Network of charter schools in New York City, assisting Explore with everything from formation to tax exemption applications to negotiating services agreements.

Insights

News